Navigation Links
Accera in Medical News

Experimental Drug Ketasyn(TM) (AC-1202) Treats Alzheimer's as Diabetes of the Brain

...n often appear 10 to 20 years earlier than other AD symptoms, targeting them may allow for earlier treatment of the disease. Based on this hypothesis, accera is developing the AD drug, Ketasyn(TM) (AC-1202), which provides glucose-deprived brain cells with an alternative energy source. Ketasyn is converted ...

A Milky Alternative to Alzheimer Drug

...togenic diet sometimes used for children with severe epilepsy. Manufacturer accera is currently hunting funding for a Phase III study, and exploring different...ned Dr. Lauren Constantini, a former Harvard scientist now with the company accera Inc. that is developing the drug. To stop Alzheimer's brain decay,...
Accera in Medical Technology

Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study

...w and similar between Ketasyn and placebo groups. accera recently completed a Phase IIb clinical trial in A...e for efficacy in cognition and short-term memory. accera plans to initiate a pivotal, Phase III multi-cente...r's disease and Age- Associated Memory Impairment. accera has other small molecule compounds in its product ...

Accera, Inc. to Present Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting

... BROOMFIELD, Colo., April 24, 2007 /PRNewswire/ -- accera Inc. announced today that topline data from its Phase IIb study of its lead compound AC-1202 in Alzheimer's disease (AD) will be presented at the annu...

Accera, Inc. Announces Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting

... BROOMFIELD, Colo., May 01, 2007 /PRNewswire/ -- accera Inc. is presenting topline data today from its Phase IIb study of its lead compound AC-1202 in Alzheimer's disease (AD) at the American Academy of Neu...
Accera in Biological Technology

Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease

BROOMFIELD, Colo., March 2 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) diseases, today launched Axona(TM) in the United States for Alzheimer's disease (AD). Axona is a first-in-class medical food for the clinical dietary...

Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease

...ona addresses the hypometabolism or defective metabolism of glucose that occurs in those areas of the brain that are involved in Alzheimer's disease. accera engages in research, development and commercialization of other clinical applications for Axona. For more information about Accera, please v...

Accera, Inc. Launches Neuera Pharmaceuticals, Inc.

... a wholly owned subsidiary and will be spun out of accera as a stand-alone company after the completion of a $12 million series A financing round. Existing accera investors have already committed to participate in...ompany, and the current small molecule pipeline at accera including the preclinical compounds, AC-0523 and A...

Accera, Inc. to Present at Upcoming Investor Conferences

...d-to-moderate Alzheimer's disease. Dr. Orndorff will provide an overview of accera and its technology pipeline and also provide an update on the successful na...ve, well-tolerated treatments. Through its proprietary scientific platform, accera is developing therapies that address metabolic deficiencies by providing an...

Dr. Thomas Werner Elected to Accera, Inc.'s Board of Directors

... impact patients with neurodegenerative disorders who are in need of effective, well-tolerated therapies. Through its proprietary scientific platform, accera is developing products that address metabolic deficiencies associated with certain neurodegenerative diseases by providing an alternative energy sourc...

Accera, Inc. Sponsors Alzheimer's Association's 2009 ICAD Conference

...f, Ph.D., Accera's founder and CEO. "As a company focused on CNS disorders, accera is committed to improving the care and quality of life of Alzheimer's patie...ive, well-tolerated therapies. Through its proprietary scientific platform, accera is developing products that address metabolic deficiencies associated with ...

Accera, Inc. Completes $35 Million Series C Financing

...estament to the confidence of our investors in the accera organization and the potential of Axona". Wolfga... a new approach to neurodegenerative diseases, and accera is a clear leader. We are pleased to support the c...pies. Through its proprietary scientific platform, accera is developing products that address metabolic defi...

Accera, Inc. Names William T. Poncy Vice President of Commercial Development

... BROOMFIELD, Colo., Oct. 10 /PRNewswire/ -- accera Inc., a privately held biotechnology company focus...Ketasyn's excellent safety and efficacy will allow accera to make a competitive entry into the multi billion... (AD) and age-associated memory impairment (AAMI). accera plans to self-commercialize Ketasyn as a medical f...

Accera, Inc. to Present at the 4th Annual BIO Investor Forum

... BROOMFIELD, Colo., Oct. 4 /PRNewswire/ -- accera Inc., a privately held biotechnology company focused on developing novel dr... October 11 at 11:00 a.m. PDT. Dr. Orndorff will provide an overview of accera and its technology platform as well as a summary of the positive data from ...
Other Tags
(Date:8/31/2014)... 31, 2014 To make it easy ... they can trust, NutriGold is shipping complimentary samples of ... has been set up to make taking advantage of ... According to Priya Khan, Director of Research and Development ... one of our products, they are entrusting us with ...
(Date:8/31/2014)... Rockville, MD (PRWEB) August 31, 2014 ... electronic health records (EHR) software firm that focuses ... overall practice success found a congruent commitment with ... In Sports . , “We create an environment ... and effortlessly, allowing more time with patients,” says ...
(Date:8/31/2014)... Richmond, CA (PRWEB) August 31, 2014 ... program of the California State Library, celebrates 30 ... and their families. Since its inception, California’s Library ... a million Californians learn to read and write. ... this volunteer-based program, the state is launching a ...
(Date:8/31/2014)... Wine only protects against cardiovascular disease (CVD) in people ... Veritas (IVV) study presented at ESC Congress today by ... Taborsky said: "This is the first randomised trial comparing ... of atherosclerosis (1) in people at mild to moderate ... was only protective in people who exercised. Red and ...
(Date:8/30/2014)... A retrievable and repositionable transcatheter aortic valve is ... according to research presented at ESC Congress 2014 ... direct flow medical (DFM) transcatheter aortic valve has ... the potential to improve transcatheter aortic valve implantation ... , Dr Pyxaras said: "TAVI is well established ...
Breaking Medicine News(10 mins):Health News:Whole-food Supplement Samples Now Offered by NutriGold 2Health News:Whole-food Supplement Samples Now Offered by NutriGold 3Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 2Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 3Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 4Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Wine only protects against CVD in people who exercise 2Health News:Retrievable transcatheter aortic valve effective and safe in real world setting 2
(Date:8/28/2014)... (ESA) is pleased to announce the selection of Dr. ... Honorary Membership acknowledges those who have served ESA for ... affairs of the Society that has reached an extraordinary ... ESA Governing Board and then voted on by the ... Awards Ceremony at Entomology 2014, ESA,s Annual Meeting in ...
(Date:8/28/2014)... expansion of marine protected areas is needed to protect ... to investigators from the Wildlife Conservation Society and other ... saving the largest numbers of species, often at the ... ecological functions. , Many vital ecological functions ... also are food for millions of people. This ...
(Date:8/28/2014)... healthier for your neighbors than traditional cigarettes, but ... a new study from USC. , Scientists studying ... decrease in exposure to harmful particles, with close-to-zero ... to some harmful metals in second-hand e-cigarette smoke ... tobacco smoke contains high levels of polycyclic aromatic ...
Breaking Biology News(10 mins):Fred Baxendale selected as Honorary Member of the Entomological Society of America 2Study finds marine protected areas inadequate for protecting fish and ocean ecology 2Second-hand e-cig smoke compared to regular cigarette smoke 2
Other Contents